ScoreWhy is Nath Bio-Genes (India) Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 6.03%
2
Flat results in Dec 25
- INTEREST(Latest six months) At Rs 8.20 cr has Grown at 79.43%
- PBT LESS OI(Q) At Rs -1.95 cr has Fallen at -158.91%
- PAT(Q) At Rs -0.15 cr has Fallen at -105.5%
3
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -0.76% over the previous quarter and collectively hold 0.32% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
4
Below par performance in long term as well as near term
- Along with generating -9.28% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Nath Bio-Genes for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Nath Bio-Genes
-9.28%
-0.25
37.51%
Sensex
10.41%
0.90
11.52%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
16.25%
EBIT Growth (5y)
29.22%
EBIT to Interest (avg)
3.83
Debt to EBITDA (avg)
2.39
Net Debt to Equity (avg)
0.23
Sales to Capital Employed (avg)
0.47
Tax Ratio
6.17%
Dividend Payout Ratio
9.59%
Pledged Shares
13.78%
Institutional Holding
0.32%
ROCE (avg)
6.76%
ROE (avg)
6.46%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
7
Industry P/E
13
Price to Book Value
0.42
EV to EBIT
9.91
EV to EBITDA
9.04
EV to Capital Employed
0.52
EV to Sales
0.98
PEG Ratio
1.43
Dividend Yield
1.34%
ROCE (Latest)
5.84%
ROE (Latest)
6.53%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
NET SALES(Q)
At Rs 65.96 cr has Grown at 78.90%
PAT(9M)
Higher at Rs 40.14 Cr
-14What is not working for the Company
INTEREST(Latest six months)
At Rs 8.20 cr has Grown at 79.43%
PBT LESS OI(Q)
At Rs -1.95 cr has Fallen at -158.91%
PAT(Q)
At Rs -0.15 cr has Fallen at -105.5%
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 0.74 cr
DEBT-EQUITY RATIO(HY)
Highest at 0.23 times
Loading Valuation Snapshot...
Here's what is working for Nath Bio-Genes
Net Sales - Quarterly
At Rs 65.96 cr has Grown at 78.90%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Here's what is not working for Nath Bio-Genes
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -1.95 cr has Fallen at -158.91%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs -0.15 cr has Fallen at -105.5%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Interest - Quarterly
Highest at Rs 4.54 cr
in the last five quarters and Increased by 24.04 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 0.74 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio - Half Yearly
Highest at 0.23 times
in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
